Labshake search
Citations for Stemcell Technologies :
1 - 50 of 453 citations for Ethyl 5 4 methoxyphenyl 5 oxovalerate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... and passaging every 4-5 days using ReLeSR (StemCell technologies). hES-qualified Matrigel (Corning ...
-
bioRxiv - Bioengineering 2024Quote: ... On day 4 of differentiation 5 μM IWP4 (Stem Cell Technologies), 2.5 ng/ml BMP4 ...
-
bioRxiv - Immunology 2023Quote: ... For 5-azacytidine (5-aza; Stem Cell Technologies) and trehalose 6,6’-dimycolate (TDM ...
-
bioRxiv - Molecular Biology 2023Quote: ... Every 4-5 days cells were passaged using ReLeSR reagent (Stemcell tech, 05872).
-
bioRxiv - Cell Biology 2023Quote: ... Routine passaging was performed every 4-5 days using ReLeSR (Cat. # 05873; STEMCELL Technologies) according to manufacturer’s instructions in E8/VTN or by treatment with Collagenase IV (Cat ...
-
bioRxiv - Molecular Biology 2022Quote: ... Cells were passaged every 4 to 5 days using ReLeSR (StemCell Technologies, catalog no. 05872). We performed characterization of our iPSCs by immunofluorescence ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells were then treated with Wnt pathway inhibitor IWP-4 (5 μM) (Stemcell Technologies, #72552) for 48 hours followed by CM(- ...
-
bioRxiv - Bioengineering 2023Quote: ... Cells were then treated with Wnt pathway inhibitor IWP-4 (5 µM) (Stemcell Technologies, #72552) for 48 hours followed by CM(- ...
-
bioRxiv - Neuroscience 2024Quote: ... in a feeder free fashion and passaged every 4∼5 days at a 1:4∼1:6 ratio using ReLeSR (Stemcell technologies) as described previously 88,95 ...
-
bioRxiv - Cancer Biology 2022Quote: ... at a density of 4-5×105 cells per well in Myelocult medium (H5100, Stem Cell Technology). In the morning ...
-
bioRxiv - Cell Biology 2021Quote: ... This was followed by cardiac specification using RPMI B27-containing 5 μM IWP-4 (Stem Cell Technologies) for another 3 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... at a density of 4-5×105 cells per well in Myelocult medium (H5100, Stem Cell Technology). On the morning ...
-
bioRxiv - Cell Biology 2023Quote: ... This was followed by cardiac specification using RPMI B27-containing 5 μM IWP-4 (Stem Cell Technologies) for another 3 days ...
-
bioRxiv - Microbiology 2024Quote: ... 5 µM CHIR99021 (StemCell technologies) and 1.25% V/V DMSO) ...
-
bioRxiv - Cell Biology 2024Quote: ... This was followed by cardiac specification using RPMI B27-medium containing 5 µM IWP-4 (Stem Cell Technologies) for another 3 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5% CO2 and 5% O2 in in growth media comprised of StemSpan SFEM II (STEMCELL Technologies) base media supplemented with 20 ng/mL of TPO ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5% CO2 and 5% O2 in AML pre-culture media comprised of MyeloCult H5100 (STEMCELL Technologies) base media supplemented with 20 ng/mL each of TPO ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 µM Dorsomorphin (StemCell Technologies, 72102), 10 µM SB431542 (StemCell Technologies ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 5% FBS (StemCell Technology), L-glutamine (2 mM) ...
-
bioRxiv - Pathology 2022Quote: ... and 5 µM SB431542 (StemCell Technologies). On Days8-14 ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 unit/ml Dispase (Stemcell Technologies) and 0.05 mg/ml DNase I (Roche)) ...
-
bioRxiv - Cell Biology 2024Quote: ... 5 mg/mL dispase (STEMCELL Technologies), supplemented with 100 µg/mL DNase1 (Sigma-Aldrich) ...
-
bioRxiv - Bioengineering 2023Quote: ... 5 µM Y27632 (72034; STEMCELL Technologies), 500 nM SB-202190 (S7067 ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... 5 µM A83-01 (STEMCELL Technologies) and 10 µM forskolin (Sigma-Aldrich) ...
-
bioRxiv - Bioengineering 2021Quote: ... coated tissue culture plates and passaged regularly as cell aggregates every 4-5 days using ReLeSR (Stemcell Technologies, 05872).
-
bioRxiv - Synthetic Biology 2024Quote: ... coated tissue culture plates and passaged regularly as cell aggregates every 4-5 days using RelesR (STEMCELL Technologies, 05872). Identity of H1 cells was authenticated by the supplier ...
-
bioRxiv - Cell Biology 2023Quote: ... The medium was replaced on d1 with RPMI/B27™ minus insulin supplemented with 5 µM IWP-4 (STEMCELL Technologies). On d3 medium change was performed using RPMI/B27™ minus insulin without any supplementation ...
-
bioRxiv - Molecular Biology 2023Quote: ... Cardiomyocyte specification was completed by 3 days of culture in RPMI B27-media with 5 μM IWP-4 (STEMCELL Technologies), followed by another 7 days of culture with RPMI B27+ (RPMI 1640 GlutaMAX + 2% B27 supplement with insulin (ThermoFisher) ...
-
bioRxiv - Cell Biology 2021Quote: ... for 5 min followed by a 3 min treatment with 5 mg/mL dispase (Stem Cell Technologies, 07913) and 1 mg/mL DNase I (Sigma ...
-
Pluripotent stem cell SOX9 and INS reporters facilitate differentiation into insulin-producing cellsbioRxiv - Developmental Biology 2021Quote: ... 5 ng/ml FGF7 (Stem Cell Technologies), 2 µM IWR-1 (Selleck Chemicals ...
-
bioRxiv - Cell Biology 2021Quote: ... suplemented with 5% FBS (StemCell Technology, 06200) and the same reagents and cytokine cocktail than the methylcellulose assays (full cytokine medium) ...
-
bioRxiv - Microbiology 2022Quote: ... 5 μM Y-27632 (Stem Cell Technologies), 1 μM A-83-01 (Tocris) ...
-
bioRxiv - Neuroscience 2021Quote: ... 5 mM L-Glutamine (Stemcell Technologies; 07100), and 35 μg/ml L-Glutamic Acid (Sigma Aldrich ...
-
bioRxiv - Neuroscience 2022Quote: ... supplemented with mTeSR1 5× Supplement (StemCell Technologies), ensuring the colony sizes were around 50-100 μm in diameter ...
-
bioRxiv - Cancer Biology 2024Quote: ... 5 μM SB-431542 (StemCell Technologies, 72234), and 1 μM LDN-193189 (StemCell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 mM L-glutamine (STEMCELL Technologies, 07100), and 35 μg ml-1 of L-glutamic acid (Sigma-Aldrich ...
-
bioRxiv - Bioengineering 2023Quote: ... containing 5 μM IWP4 (STEMCELL Technologies, 72552). An additional 48 hours later (on Day 5) ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 µM FSK (STEMCELL Technologies, #100-0249) and 200 ng/ml NRG1 type III ...
-
bioRxiv - Bioengineering 2024Quote: ... and 5 μM CHIR99021 (StemCell Technologies, 72054). After 48h ...
-
bioRxiv - Neuroscience 2024Quote: ... 5 μM IWP2 (ref.72124, Stemcell Technologies) from day 0 to 7 and 50 ng/mL FGF8 (ref.100-32 ...
-
bioRxiv - Genomics 2020Quote: ... H1 cells were daily fed with fresh mTeSR1 media and passaged every 4-5 days using ReLeSR reagent (StemCell Technologies, 05872). Cells were dissociated into single cells with TrypLE Express (Thermo Fisher ...
-
Parallelized engineering of mutational models using piggyBac transposon delivery of CRISPR librariesbioRxiv - Bioengineering 2020Quote: ... cells were maintained on 6-well plates in a humidified incubator at 37°C with 5% CO2 and passaged every 3-4 days (at ∼80% confluence) using ReLeSR (Stemcell Technologies), following the manufacturer’s protocol ...
-
bioRxiv - Cell Biology 2021Quote: ... H9-hESC SOX10::GFP reporter and H20961 iPSC were passaged ∼1:6 every 4-5 days by incubating them in ReLeSR (StemCell technologies) for 1 min at room temperature ...
-
bioRxiv - Developmental Biology 2022Quote: ... they were specified into a hiPSC-CM/stromal cell mixture using RPMI B27-containing 5 µM IWP-4 (Stem Cell Technologies) followed by another 7 days of RPMI B27+ (RPMI1640 GlutaMAX + 2% B27 supplement with insulin ...
-
bioRxiv - Cancer Biology 2021Quote: IL-10 polarized human DCs (3×10^4/well) were incubated with allogeneic CD8+ T cells (1.5 × 10^5/well) in T cell media (Stem Cell Technologies) in 96 well flat bottom tissue culture plates for 4 days ...
-
bioRxiv - Neuroscience 2024Quote: ... iPSC cultures were passaged every 4-5 days when the colonies reached 80% confluency using the dissociation reagent ReLeSR (STEMCELL Technologies) according to the manufacturer’s protocol ...
-
bioRxiv - Cell Biology 2024Quote: ... iPSCs were passaged with Versene solution (Paneco, Russia) at a ratio of 1:15 – 1:20 every 4–5 days with ROCK-inhibitor (StemCell Technologies).
-
bioRxiv - Cell Biology 2023Quote: ... 5% CO2) at a cell concentration of 5 × 105/mL in StemSpan Serum-Free Expansion Medium II (STEMCELL Technologies) supplemented with 100 ng/mL of human recombinant SCF ...
-
bioRxiv - Cell Biology 2023Quote: ... hiPSCs and hESCs were cultured in mTESR-Plus medium (StemCell Technologies at 5% O2, 5% CO2 and 37 °C). The cells were characterized based on expression of stemness markers (Oct4 ...
-
bioRxiv - Genomics 2021Quote: ... cells were centrifuged (350 x g for 5 minutes) and resuspended in 5 mL of prewarmed 0.25% trypsin/EDTA (#07901, Stemcell Technologies) at 37°C for 5 minutes ...